← Back to patent-cliff list

CAS 848942-61-0

2-(4-((4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)-N-methylacetamide

Codes: Sapitinib

Application context (from source-drug indications)

Non-small cell lung cancerSapitinibMetastatic breast cancerSapitinibNeoplasmSapitinibBreast cancerSapitinibOesophageal cancerSapitinibGastric cancerSapitinib

Source drugs (routes using this intermediate)

DrugTierExpiry
SapitinibTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.